Name

DB Biotech

Description

DB Biotech introduced to the world market a new quality of rabbit monospecific antibodies. Their production is based on a unique technology (owned by the company) with resulting antibodies having a significantly higher affinity and avidity compared to the antibodies created by using the standard procedures without any limitation in their use. This is based on the fact, that classical monoclonal and polyclonal technologies for the production of antibodies are based on selection of a fraction of immunoglobulins from a huge pool of possible variations, where our technology is able to produce antibody to one, selected, single, target epitope. DB Biotech currently offers three lines of antibodies, one for immunohistochemistry, one for Western Blot, and one for Flow Cytometry application. We also produce a dual, mouse/rabbit detection system for applications in immunohistochemistry. Our portfolio contains more than 140 products; many of them already sold in more than 35 countries worldwide. All our products are manufactured under GMP conditions, all are IVD CE certified. The company itself is proudly ISO 9001:2008 and ISO 13485:2003 certified (Lloyd’s Register LRQA, London, UK). 

Location

Kosice, Slovakia 

Web page

http://www.dbbiotech.com 

Contact information

Dr. Peter Molnar DVM, PhD.
Director of Sales
DB Biotech, spol. s r.o.
Popradska 80, 040 11 Kosice
Slovak Republic

Tel: +421 55 789 00 22
Cell: +421 917 647 565
Fax: +421 55 789 00 24
Email: molnar@dbbiotech.com
Web: www.dbbiotech.com
 

# Antibodies

98 

Users

Peter Molnar